Development and clinical validation of deep learning-based immunohistochemistry prediction models for subtyping and staging of gastrointestinal cancers.

Abstract

Authors

• Junxiao Wang
  School of Geographic and Oceanographic Sciences, Nanjing University, Nanjing 210023, China. dz1427034@smail.nju.edu.cn.
• Shiying Zhang
  Department of Pathology, Renmin Hospital of Wuhan University, Wuhan, China.
• Jia Li
  Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan Tsuihang New District, Guangdong, 528400, PR China; School of Pharmacy, Zunyi Medical University, Zunyi, 563000, PR China; National Center for Drug Screening, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, PR China.
• Mei Deng
  Department of Neurosurgery, Guizhou Provincial People's Hospital, Guiyang, China.
• Zhi Zeng
  Department of Pathology, Renmin Hospital of Wuhan University, Wuhan, China.
• Zehua Dong
  Department of Internal Medicine, Renmin Hospital of Wuhan University, 99 Zhangzhidong Road, Wuhan, 430060, Hubei Province, China.
• Fangfang Chen
  College of Information Science and Engineering, Xinjiang University, Urumqi, Xinjiang, China.
• Wen Liu
  Department of Dermatology, Air Force General Hospital, PLA Beijing 100142, China.
• Lianlian Wu
  Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan, China.
• Honggang Yu
  Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan, China.

Keywords

No keywords available for this article.

External Resources